The long-term goal of this project is to develop novel methods for the detection of nucleotides, oligonucleotides, and modified nucleotides such as DNA adducts by mass spectrometry. DNA adducts are important because they are formed during chemical carcinogenesis as well as during anti-cancer chemotherapy. However, DNA adducts are not routinely monitored due to difficulties associated with their detection. Mass spectrometry is a promising method for the detection of DNA adducts because it can detect almost any type of adduct, and in addition mass spectrometers can provide structural information. The work presented here shows successful detection of nucleotides and oligonucleotides of various sizes. Specific sizes detected include mononucleot...
The 32P-postlabelling assay is widely used for detection of carcinogen-DNA adducts and other types o...
High-Performance Liquid Chromatography for Analysis of 32P-Postlabel...
An analytical method for the structure differentiation of arylamine modified oligonucleotides (ODNs)...
The long-term goal of this project is to develop novel methods for the detection of nucleotides, oli...
A new approach is described for the enzymatic digestion of DNA yielding oligonucleotides ranging fro...
Carcinogens have shown a sequence specificity in the formation of DNA adducts. Understanding this s...
Exogenous and endogenous sources of chemical species can react, directly or after metabolic activati...
The carcinogens to which humans are exposed are normally in the form of complex mixtures, and much e...
Introduction Oligonucleotides are short nucleic acid chains, usually 19-27mer long. They bind to the...
The measurement of DNA adducts, the covalent modifications of DNA upon the exposure to the environme...
A further development of an HPLC method to analyze 32P-postlabeled DNA adducts is presented. The met...
Chemically modified nucleotides, which are not normally present in genetic material, are called DN A...
Covalent binding of endo- or exogenous chemicals to DNA results in the formation of DNA adducts whic...
The first oligonucleotide therapeutic was approved by the Food and Drug Administration in 1998, and ...
ABSTRACT: Recent studies have demonstrated that various DNA adducts can be detected in human tissues...
The 32P-postlabelling assay is widely used for detection of carcinogen-DNA adducts and other types o...
High-Performance Liquid Chromatography for Analysis of 32P-Postlabel...
An analytical method for the structure differentiation of arylamine modified oligonucleotides (ODNs)...
The long-term goal of this project is to develop novel methods for the detection of nucleotides, oli...
A new approach is described for the enzymatic digestion of DNA yielding oligonucleotides ranging fro...
Carcinogens have shown a sequence specificity in the formation of DNA adducts. Understanding this s...
Exogenous and endogenous sources of chemical species can react, directly or after metabolic activati...
The carcinogens to which humans are exposed are normally in the form of complex mixtures, and much e...
Introduction Oligonucleotides are short nucleic acid chains, usually 19-27mer long. They bind to the...
The measurement of DNA adducts, the covalent modifications of DNA upon the exposure to the environme...
A further development of an HPLC method to analyze 32P-postlabeled DNA adducts is presented. The met...
Chemically modified nucleotides, which are not normally present in genetic material, are called DN A...
Covalent binding of endo- or exogenous chemicals to DNA results in the formation of DNA adducts whic...
The first oligonucleotide therapeutic was approved by the Food and Drug Administration in 1998, and ...
ABSTRACT: Recent studies have demonstrated that various DNA adducts can be detected in human tissues...
The 32P-postlabelling assay is widely used for detection of carcinogen-DNA adducts and other types o...
High-Performance Liquid Chromatography for Analysis of 32P-Postlabel...
An analytical method for the structure differentiation of arylamine modified oligonucleotides (ODNs)...